2005
DOI: 10.1016/j.febslet.2005.10.036
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between HIF‐1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF‐1α

Abstract: Hypoxia inducible factor-1a (HIF-1a) is a central component of the cellular responses to hypoxia. Hypoxic conditions result in stabilization of HIF-1a and formation of the transcriptionally active HIF-1 complex. It was suggested that mammalian ARD1 acetylates HIF-1a and thereby enhances HIF-1a ubiquitination and degradation. Furthermore, ARD1 was proposed to be downregulated in hypoxia thus facilitating the stabilization of HIF-1a. Here we demonstrate that the level of human ARD1 (hARD1) protein is not decreas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
71
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(74 citation statements)
references
References 26 publications
2
71
1
Order By: Relevance
“…GST, glutathione-S-transferase; HBx, HBV regulatory protein; HIF-1a, hypoxia-inducible factor-1a; ODD, oxygen-dependent degradation; WT, wild type. Jeong et al, 2002;Qian et al, 2006), the acetylation hypothesis remains controversial since human ARD1 does not, at least directly, acetylate HIF1a (Arnesen et al, 2005;Bilton et al, 2005Bilton et al, , 2006Fisher et al, 2005;Murray-Rust et al, 2006). Instead, diverse other mechanisms have been proposed for the HDAC inhibitor-induced HIF-1 regulation; Kong et al (2006) showed that HDAC inhibitors induced the proteasomal degradation of HIF-1a by interacting with HSP70 and thereby disrupted the HSP70/HSP90 axis function.…”
Section: Discussionmentioning
confidence: 99%
“…GST, glutathione-S-transferase; HBx, HBV regulatory protein; HIF-1a, hypoxia-inducible factor-1a; ODD, oxygen-dependent degradation; WT, wild type. Jeong et al, 2002;Qian et al, 2006), the acetylation hypothesis remains controversial since human ARD1 does not, at least directly, acetylate HIF1a (Arnesen et al, 2005;Bilton et al, 2005Bilton et al, , 2006Fisher et al, 2005;Murray-Rust et al, 2006). Instead, diverse other mechanisms have been proposed for the HDAC inhibitor-induced HIF-1 regulation; Kong et al (2006) showed that HDAC inhibitors induced the proteasomal degradation of HIF-1a by interacting with HSP70 and thereby disrupted the HSP70/HSP90 axis function.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Arnesen et al [27] have reported evidence that the stability of HIF-1a is not regulated by hARD1 and that the level of hARD1 is not hypoxically regulated. These authors also reported evidence that hARD1 does not acetylate HIF1a, but importantly did demonstrate an interaction between hARD1 and HIF-1a.…”
Section: Note Added In Proofmentioning
confidence: 99%
“…In addition, ARD1 has been reported to show q-protein acetylation activity in mammalian cells; for example, it acetylates Lys 532 in hypoxia-inducible factor 1a (HIF-1a) and thereby degrades HIF-1a via the ubiquitin-proteasome system (7). However, two research groups recently posed questions about the involvement of ARD1 in HIF-1a regulation (8,9).…”
Section: Introductionmentioning
confidence: 99%